http://orcid.org/0000-0003-1326-1288
References
- Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med.. 2003;348(14):1365–1375.
- Volkman R, Offen D. Concise review: mesenchymal stem cells in neurodegenerative diseases. Stem Cells. 2017;35(8):1867–1880.
- Skovronsky DM, Lee V-Y, Trojanowski JQ. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol Mech Dis.. 2006;1(1):151–170.
- Linares GR, Chiu C-T, Scheuing L, et al. Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington’s disease. Exper Neurol. 2016;281:81–92.
- Wang Y, Ji X, Leak RK, et al. Stem cell therapies in age-related neurodegenerative diseases and stroke. Ageing Res Rev. 2017;34:39–50.
- Wei N, Yu SP, Gu X, et al. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell Transplant. 2013;22(6):977–991.
- Esfahani M, Karimi F, Afshar S, et al. Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy. Expert Opin Biol Ther. 2015;15(12):1739–1755.
- Giaccia A, Siim BG, Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov. 2003;2(10):803–811.
- Najafi R, Sharifi AM. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats. Expert Opin Biol Ther. 2013;13(7):959–972.
- Pourjafar M, Saidijam M, Mansouri K, et al. All‐trans retinoic acid preconditioning enhances proliferation, angiogenesis and migration of mesenchymal stem cell in vitro and enhances wound repair in vivo. Cell Prolif. 2017;50(1):e12315.
- Pourjafar M, Saidijam M, Mansouri K, et al. Cytoprotective effects of endothelin‐1 on mesenchymal stem cells: an in vitro study. Clin Exp Pharmacol Physiol. 2016;43(8):769–776.
- Malih S, Saidijam M, Mansouri K, et al. Promigratory and proangiogenic effects of AdipoRon on bone marrow-derived mesenchymal stem cells: an in vitro study. Biotechnol Lett. 2017;39(1):39–44.
- Olivera A, Kohama T, Edsall L, et al. Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol. 1999;147(3):545–558.
- Ader I, Malavaud B, Cuvillier O. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. Cancer Res. 2009;69(9):3723–3726.
- Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4(5):397–407.
- Hisano Y, Nishi T, Kawahara A. The functional roles of S1P in immunity. J Biochem. 2012;152(4):305–311.
- Ader I, Brizuela L, Bouquerel P, et al. Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1α during hypoxia in human cancer cells. Cancer Res. 2008;68(20):8635–8642.